Genital Neoplasms, Female

A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations

Patient Journey in Advanced Gynecologic Cancers

Dose Escalation Study of BIBF 1120 in Patients With Advanced Gynaecological Malignancies

Characterization of the Intestinal and Vaginal Microbiota in Long-term Survivors of Gynecological Cancer

RT for Cervical Adenocarcinoma/adenosquamous Carcinoma

Anlotinib Combined With Carboplatin/Paclitaxel as First-line Treatment in Patients With Advanced Ovarian Cancer

Intra-tumor Injection of Oncolytic Viruses H101 Combined With or Without Radiotherapy in Refractory/Recurrent Gynecological Malignancies

Self-Testing Options in the Era of Primary HPV Screening for Cervical Cancer Trial

Cognitive Behavioral Effects on Sleep, Pain, and Cytokines in Gynecologic Cancer

Pembrolizumab and Lenvatinib for Platinum- Sensitive Recurrent Ovarian Cancer

Pembrolizumab in Subjects With Incurable Platinum-Refractory Germ Cell Tumors

A Randomized Controlled Trial of an Online Support Group for Sexual Distress Due to Gynecologic Cancer

Efficacy and Safety of Niraparib Combined With Bevacizumab in Platinum Refractory/Resistant Recurrent Ovarian Cancer

Anlotinib Combined With Dose-reduced Olaparib in Patients With Platinum-Sensitive Recurrent Ovarian Cancer

Effect of Early Compression and Exercise on Lymphedema Incidence in Patients With Gynecological Cancer

Overcoming Obstacles to Clinical Trials Enrollment Through a Navigator Program

Limiting Chemotherapy Side Effects by Using Moxa

Efficacy of Two Antiemetic Regimens in Patients Receiving Radiotherapy and Concomitant Weekly Cisplatin

A Phase I Study of CCI-779 (Temsirolimus) in Combination With Topotecan in Patients With Gynecologic Malignancies

Study to Evaluate the Clinical Benefit Response in Cancer Patients With Advanced Disease With AMT2003 Versus Placebo